Retinopathy Associated with Interferon and Ribavirin Therapy in Patient with Hepatitis [C]
Hend Awad El Mashtoly;
Abstract
Hepatitis C (HCV) was first identified in 1989 and is estimated to affect 170 million people worldwide.
Egypt has possibly the highest HCV prevalence in the world; 10%–20% of the general population is infected and HCV is the leading cause of HCC and chro
Egypt has possibly the highest HCV prevalence in the world; 10%–20% of the general population is infected and HCV is the leading cause of HCC and chro
Other data
| Title | Retinopathy Associated with Interferon and Ribavirin Therapy in Patient with Hepatitis [C] | Other Titles | إعتلال الشبكية المصاحب لإستخدام الإنترفيرون والريبافيرين كعلاج لمرضى الالتهاب الكبدي [ج] | Authors | Hend Awad El Mashtoly | Keywords | Retinopathy Associated with Interferon and Ribavirin Therapy in Patient with Hepatitis [C] | Issue Date | 2011 | Description | Hepatitis C (HCV) was first identified in 1989 and is estimated to affect 170 million people worldwide. Egypt has possibly the highest HCV prevalence in the world; 10%–20% of the general population is infected and HCV is the leading cause of HCC and chro |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 102022Binder7.pdf | 218.01 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.